|
 News
Customer
Stories
About
Us
Contacts
|
 Leading
Pharmaceutical Company Selects
STARLIMS
for $2.1 million Global LIMS Project
STARLIMS to serve R&D and Quality
Assurance laboratories in North America, Europe and Asia
HOLLYWOOD, Fla., January 25, 2008 -
STARLIMS Technologies Ltd. (Nasdaq:LIMS), a leading provider of
laboratory information management systems (LIMS), today
announced that it has been selected by one of the world’s
leading pharmaceutical companies for a $2.1 million LIMS
project. STARLIMS v10 will be implemented in the pharmaceutical
company’s Research and Development and Quality Assurance
laboratories in North America, Europe and Asia.
 A
LIMS for Global Synergy
“Being selected by one of the world’s largest
pharmaceutical companies is clearly a vote of confidence in our
vision of creating a single web-based platform for laboratory
informatics, covering multiple lab disciplines and reaching
across the globe,” said Jeff Ferguson COO at STARLIMS. “We are
seeing more companies standardizing their LIMS solutions across
the enterprise and we believe STARLIMS v10 is well positioned to
meet this demand.”
Enhanced
Collaboration across Disciplines and Continents
Implementing STARLIMS will facilitate the
sharing of scientific data and best practices across multiple
laboratory sites. The pharmaceutical customer intends to
standardize on STARLIMS, beginning with eight sites. One of the
key considerations the customer had in selecting STARLIMS was
its scalability, a benefit of its entirely web-based
architecture. In addition, STARLIMS offers multilingual and
multi-time zone support, important considerations for
distributed LIMS implementations.
Streamlined
IT Requirements
By standardizing on STARLIMS, the company is
expected to enhance regulatory compliance and traceability, by
facilitating more consistent reporting and enhancing data
security. The web based STARLIMS v10 system will simplify
deployment, validation, scale up and upgrade of the system while
reducing resource requirements for ongoing maintenance.
About
STARLIMS
STARLIMS Technologies Ltd. (Nasdaq:LIMS) is a
leading provider of laboratory information management systems
(LIMS), with over 20 years of LIMS experience. The Company's
flagship product, STARLIMS®, improves the reliability of
laboratory sampling processes, supports compliance with domestic
and international regulations and industry standards, and
provides comprehensive reporting, monitoring and analysis
capabilities. STARLIMS software is used for quality assurance
and control, testing and monitoring, and research and
development in government, manufacturing and life sciences
organizations. With operations in the United States, Canada, the
United Kingdom, Israel and Hong Kong, the company serves over
500 organizations in 40 countries. For more information, please
see http://www.starlims.com
Safe
Harbor for Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements
involve known and unknown risks and uncertainties which could
cause the actual results, performance or achievements of the
company to be materially different from those which may be
expressed or implied by such statements, including, among
others, changes in general economic and business conditions,
changes in demand for products and services, the timing and
amount or cancellation of orders, loss of market share and other
risks detailed from time to time in STARLIMS's filings from time
to time with the Securities and Exchange Commission. Such
filings contain and identify these and other important factors
that could cause actual results to differ materially from those
contained in our projections or forward-looking statements.
Shareholders and other readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only
as of the date on which they are made. We undertake no
obligation to update publicly or revise any forward-looking
statement.
### |
|
